Based on the forecast, hospital discharges for malignant neoplasm of the skin in the UK are expected to decrease yearly from 2024 to 2028, starting at 9.6 discharges per hundred thousand persons in 2024 to 7.3 in 2028. The figures for 2023 stand unrevealed in this dataset. From 2024 to 2025, the decline is anticipated to be approximately 6.25%, followed by a 6.67% decrease in 2025-2026. Between 2026 and 2027, a 5.95% drop is projected, and a further 7.59% reduction from 2027 to 2028. The compound annual growth rate (CAGR) suggests an average decline rate of approximately 6.42% from 2024 to 2028.
Future trends to watch for include advancements in early detection and preventive healthcare measures that may further influence hospitalization rates. Additionally, shifts in public health policies or breakthroughs in dermatological treatments could alter these projections significantly.
